AzTrials
AzTrials

Dentin HypersensitivityNCT04887181

The Effects of Different Dentin Hypersensitivity Treatment Methods on Quality of Life

A study testing Teethmate Desensitizer, Gluma Desensitizer and Hybrid Bond in people with Dentin Hypersensitivity, run by Kırıkkale University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study was to evaluate the effects of a self etch adhesive resin and two desensitizing agents(Calcium phosphate, 5% glutaraldehyde) in treatment of dentin hypersensitivity on the quality of life of individuals. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Dentin Hypersensitivity
What is being tested?
Teethmate Desensitizer, Gluma Desensitizer and Hybrid Bond
Could I receive a placebo?
No, everyone receives an active treatment
How many people
69 participants
Where
1 siteTurkey (Türkiye)
Study dates
4 Mar 2020to 1 Mar 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Not having any systemic disease,
  • 18 years and older,
  • At least one tooth complaining of dentin hypersensitivity (Schiff score> 1),
  • The acceptance of the volunteers participating in the research.

Who cannot join

  • Active periodontal disease,
  • Periodontal surgery for the last 3 months,
  • Use of desensitizing toothpaste or mouthwash in the last 3 months,
  • Long-term use of analgesic and anti-inflammatory drugs,
  • Having a history of allergies,
  • Women during pregnancy or breastfeeding,
Show all 11Show fewer
  • Parafunctional habits (bruxism, teeth grinding etc.),
  • The presence of caries, pulpitis or restoration in teeth,
  • Tooth tissue loss due to erosion, abrasion and abfraction,
  • Congenital anomalies,
  • Cracked teeth were not included in the study.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Kırıkkale University Faculty of Dentistry, Department of Restorative Dentistry

    Kirikkale, Yahşihan/Kırıkkale, 71450

Other trials in Turkey (Türkiye)

About this study

The aim of this study was to evaluate the effects of a self etch adhesive resin and two desensitizing agents(Calcium phosphate, 5% glutaraldehyde) in treatment of dentin hypersensitivity on the quality of life of individuals.

Read the detailed description

This in-vivo study was done among 69 participants who reported at least one sensitivite tooth(Schiff Sensitivity Score >1) as a result of the clinical examination. Participants were randomly divided into three treatment groups(n=23):

  1. Tetracalcium phosphate and dicalcium phosphate containing desensitizer (Teethmate Desensitizer) II. %35 hydroxyethyl methacrylate and %5 glutaraldehyde containing desensitizer (Gluma Desensitizer) III. Self-etch adhesive resin (Hybrid Bond) These materials used in treatment of dentin hypersensitivity in 6 months clinical follow-up and the effects on the quality of life of individuals were evaluated with Dentine Hypersensitivity Experience Questionnaire (DHEQ).
Being tested
Teethmate Desensitizer, Gluma Desensitizer, Hybrid Bond
Keywords
Dentin Hypersensitivity, Desensitizing Agent, Adhesive Resin
Medical subject headings
Dentin Sensitivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Teethmate DesensitizerOther

    Powder and liquid contained in the material were mixed. It was applied to the buccal surface of the sensitive tooth. then it was washed away from the tooth surface. 1-4 sessions were applied until the sensitivity disappeared.

  • Gluma DesensitizerOther

    The material was applied to the buccal surface of the tooth with sensitivity. It was washed with water and removed from the tooth surface. 1-4 sessions were applied until the sensitivity disappeared.

  • Hybrid BondOther

    It was applied to the buccal surface of the sensitive tooth with an applicator. It was cured with a LED light device. Dentin sensitivity was checked with evaporative air application. The process was repeated until the sensitivity disappeared.

Study groups in NCT04887181
Study groupRoleWhat they receive
Teethmate DesensitizerActive comparatorTetracalcium phosphate and dicalcium phosphate containing desensitizer
Receives: Other: Teethmate Desensitizer
Gluma DesensitizerActive comparator%35 hydroxyethyl methacrylate and %5 glutaraldehyde containing desensitizer
Receives: Other: Gluma Desensitizer
Hybrid BondActive comparatorSelf-etch adhesive resin
Receives: Other: Hybrid Bond

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Schiff Cold Air Sensitivity Scale Scores

    Average scores based on Schiff cold air sensitivity scale after evaporative air application. The Schiff score ranges from 0 to 3. Minimum value is 0, maximum value is 3. An increase in the score from 0 to 3 indicates an increase in sensitivity.

    Measured: Before treatment, immediately after treatment, 1 week, 1 month, 3 month and 6 month

  2. Visual Analog Scale(VAS) Scores

    Average scores based on Visual Analog Scale(VAS) after applying evaporative air. The VAS score ranges from 0 to 10. The minimum value is 0 and the maximum value is 10. A score of 0 is defined as "no pain" while a score of 10 is defined as "intolerable pain".

    Measured: Before treatment, immediately after treatment, 1 week, 1 month, 3 month and 6 month

  3. Dentin Hypersensitivity Experience Questionnaire (DHEQ) scores

    Data obtained after individuals complete the Dentin Hypersensitivity Experience Questionnaire. The decrease in the measured scores over time indicates that the quality of life has improved.

    Measured: Change from baseline quality of life at 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 May 2021
  2. Study start4 Mar 2020
  3. Primary completion4 Sep 2020
  4. Study completion1 Mar 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
69 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04887181
Sponsor's protocol ID
28/02
Status last verified
May 2021
First submitted
5 May 2021
Last updated
14 May 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: all collected IPD

Publications

  • Mason S, Burnett GR, Patel N, Patil A, Maclure R. Impact of toothpaste on oral health-related quality of life in people with dentine hypersensitivity. BMC Oral Health. 2019 Oct 22;19(1):226. doi: 10.1186/s12903-019-0919-x.

    PubMed 31640741

Questions about this trial

What is this clinical trial studying?

A study testing Teethmate Desensitizer, Gluma Desensitizer and Hybrid Bond in people with Dentin Hypersensitivity, run by Kırıkkale University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Schiff Cold Air Sensitivity Scale Scores (time frame: Before treatment, immediately after treatment, 1 week, 1 month, 3 month and 6 month). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04887181, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in